Cerus Corp
Symbol: CERS (NASDAQ)
1.25
▲ (5.51%) 0.065
Company Description:
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Key Stats
- Today's Open: $1.19
- Today's High: $1.275
- Today's Low: $1.19
- Today's Volume: 2.39M
- Yesterday Close: $1.18
- Yesterday High: $1.28
- Yesterday Low: $1.17
- Yesterday Volume: 2.27M
- Last Min Volume: 200
- Last Min High: $1.245
- Last Min Low: $1.245
- Last Min VWAP: $1.245
Company Profile
- Name: Cerus Corp
- Website: https://www.cerus.com
- Listed Date: 1997-01-31
- Location: CONCORD, CA
- Market Status: Active
- CIK Number: 0001020214
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $226.20M
- Round Lot: 100
- Outstanding Shares: 191.70M
- Asset Type: CS
RECENT FILINGS FOR CERS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-25 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-05 | S-8 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-30 | SCHEDULE 13G/A | View |
| 2025-06-23 | 8-K | View |
| 2025-06-09 | 8-K | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-05-30 | SD | View |
| 2025-05-23 | DEFA14A | View |
| 2025-05-01 | 10-Q | View |
| 2025-05-01 | 8-K | View |
| 2025-04-23 | ARS | View |
Latest News on CERS